Nitric oxide (NO) is an inhibitor of gastrointestinal smooth muscle. Model systems of the gut predict that NO will complex with biological thiol (SH) groups, yielding S-nitrosothiols (RS-NO), which may limit the propensity to form mutagenic nitrosamines. Nitric oxide (NO)' and derivatives thereof have been demonstrated to be potent inhibitors of gastrointestinal smooth muscle (1-5). Nitric oxide synthase (NOS), the enzyme responsible for generating NO via the oxidation of the guanidino nitrogen of L-arginine, has been localized to a population of neurons in the myenteric plexus of rodent small bowel and in the myenteric and mucosal ganglia of rodent and canine colon (6-9). NO has been proposed as the inhibitory transmitter responsible for nonadrenergic noncholinergic (NANC) neural activity in gastrointestinal smooth muscle (10-18).
Introduction
Nitric oxide (NO) is an inhibitor of gastrointestinal smooth muscle. Model systems of the gut predict that NO will complex with biological thiol (SH) groups, yielding S-nitrosothiols (RS-NO), which may limit the propensity to form mutagenic nitrosamines. The inhibitory effects of NO and its biologically relevant adducts on sphincter of Oddi (SO) motility have been inferred from animal studies; however, their importance in regulating human SO is not known. The objectives of this study were to (a) provide histologic confirmation of nitric oxide synthase (NOS) in human SO; (b) characterize the pharmacology of S-nitroso-N-acetylcysteine (SNAC), an exemplary S-nitrosothiol, on SO motility in a rabbit model; and (c) study the effects of topical SNAC on SO motility in humans.
Immunocytochemical and histochemical identification of NOS was performed in human SO. The pharmacologic response of SNAC was defined in isolated rabbit SO using a standard bioassay. Topical SNAC was then applied to the duodenal papilla in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) and biliary manometry.
NOS was localized to nerve fibers and bundles of the SO in rabbits and humans. SNAC inhibited spontaneous motility (frequency and amplitude) as well as acetylcholineinduced elevations in SO basal pressure in the rabbit model. In patients undergoing ERCP and biliary manometry, topical SNAC inhibited SO contraction frequency, basal pressure, and duodenal motility.
NOS is localized to neural elements in human SO, implicating a role for NO in regulating SO function. Supporting this concept, SNAC is an inhibitor of SO and duodenal motility when applied topically to humans during ERCP. Our data suggest a novel clinical approach using local NO donors to control gastrointestinal motility and regulate sphincteric function. (J. Clin. Invest. 1994 . 94:1792-1798.) Key words: nitric oxide * S-nitroso-N-acetylcysteine * nitrosothiol * endoscopic retrograde cholangiopancreatography * sphincter of Oddi Nitric oxide (NO)' and derivatives thereof have been demonstrated to be potent inhibitors of gastrointestinal smooth muscle (1) (2) (3) (4) (5) . Nitric oxide synthase (NOS), the enzyme responsible for generating NO via the oxidation of the guanidino nitrogen of L-arginine, has been localized to a population of neurons in the myenteric plexus of rodent small bowel and in the myenteric and mucosal ganglia of rodent and canine colon (6) (7) (8) (9) . NO has been proposed as the inhibitory transmitter responsible for nonadrenergic noncholinergic (NANC) neural activity in gastrointestinal smooth muscle (10) (11) (12) (13) (14) (15) (16) (17) (18) .
The high reactivity of NO with a variety of biologically relevant molecules (19) (20) (21) (22) (23) and its resulting short half-life under physiologic conditions have lead several groups to postulate that NO-like activity may be stabilized in vivo (20) (21) (22) (23) . In particular, S-nitrosothiols (RS-NO), formed from the nitrosation of SH groups of low molecular weight thiols and proteins, are a class of relatively stable NO adducts that form under physiologic conditions and retain smooth muscle inhibitory activity in gastrointestinal (GI) and non-GI tissue (3, 13, (20) (21) (22) (23) (24) (25) . Moreover, the formation of RS-NO in the GI tract has been suggested to represent a protective mechanism that limits the generation of mutagenic nitrosamines (19) . Indeed, experiments in model systems reproducing conditions found in the gut indicate that a significant portion of NO bioactivity may exist as RS-NO (26) . S-nitroso-N-acetylcysteine (SNAC) is a well characterized model S-nitrosothiol that is particularly stable under physiologic conditions and has documented smooth muscle relaxant properties (22, 23, 25) ; its thiol component, Nacetylcysteine, is used clinically as a mucolytic agent and as treatment for acetaminophen toxicity.
There have been no studies localizing NOS in sphincter of Oddi (SO) and few studies exploring the effect of NO on SO function. A neuronal (constitutive; nc-NOS) NOS has been demonstrated in guinea pig SO homogenates, inhibition of which results in enhanced resting and stimulated tonic and phasic activity, as well as attenuation in field stimulation-induced SO relaxation (27) (28) (29) identified neuronal cell bodies and nerve fibers with positive diaphorase staining, indicative of NOS activity, in circular strips of oppossum SO. These investigators found that N-nitro-L-arginine methyl ester inhibited electrical field stimulation-induced relaxations and that this inhibition was attenuated by L-arginine and oxyhemoglobin (an NO scavanger) and mimicked by sodium nitroprusside (an NO donor). These studies support the concept that endogenous NO acts as an inhibitory modulator of resting SO tone and duodenal motility in animals.
In this study, NOS, the source of endogenous NO generation, was localized to neural elements in the submucosa of human and rabbit SO, using histochemical and immunohistochemical techniques. These findings, suggesting important functions for NO, were extended to an ex vivo rabbit SO preparation in which the pharmacological response of SNAC exhibited potent inhibitory properties. Because inhibition of motor activity in the duodenum and SO are therapeutic goals during endoscopic retrograde cholangiopancreatography (ERCP), we postulated that topical SNAC might be an effective agent in facilitating ERCP via direct action on the ampulla and periampullary duodenum. SNAC was applied locally to the ampulla and periampullary duodenal mucosa of patients undergoing ERCP and biliary manometry and was shown to both inhibit duodenal motility and lower sphincter of Oddi contraction frequency and basal pressure. These findings demonstrate that NO is an inhibitor of sphincter of Oddi function in humans and provide the basis for the development of novel, topically active agents to control intestinal motility and sphincteric functions.
Methods

Histochemical and immunocytochemical localization
Rabbit sphincter of Oddi were isolated as described below. A human sphincter of Oddi was obtained at surgery for nonmalignant disease under a "discarded materials" protocol approved by the Institutional Committee on Human Subjects and Research. The tissue was snap frozen, and cryostat sections (8 pm were prepared for immuno or histochemical staining.
NADPH diaphorase staining. Sections were fixed in fresh 2% buffered paraformaldehyde for 10 min and rinsed with phosphate-buffered saline (PBS). The slides were then covered with a reaction mixture consisting of 0.25 mg/ml nitroblue tetrazolium, 1 mg/ml NADPH, and 0.5% Triton X-100 in 0.1 M Tris buffer, pH 7.6. Preliminary experiments indicated that 1 h provided optimal staining, and this duration of incubation was used in subsequent experiments reported below. After washing in PBS, sections were covered with glycerol mounting medium and coverslips were applied. Controls included omission of substrate and inclusion of 15 mM p-nitrophenylphosphate to inhibit endogenous phosphatases that can convert NADPH to NADH and cause false positive staining by NADH dehydrogenases (31) .
NOS immunolocalization. Polyclonal rabbit anti-nc-NOS (neuronal) was used after affinity purification as previously described (6) . Immunohistochemistry was performed on human tissue only, using a standard avidin solution immunoperoxidase procedure (32) followed by hematoxylin counterstaining. Controls included use of buffer alone or dilutions of nonspecific purified rabbit IgG in the primary layer.
Isolation of rabbit sphincter of Oddi
Male New Zealand White rabbits (3-33/2 lb; Milbrook Farms, Amherst, MA) were anesthetized with intravenous pentobarbital after cannulation of a marginal ear vein. After deep anesthesia was obtained, the abdomen was opened at the midline, and the gastric antrum and contiguous duodenum were isolated, removed en block, and transferred to ice-cold oxygenated Krebs buffer at pH 7.4. The Krebs buffer consisted of (mM): NaCl 118, NaHCO3 25, D-dextrose 11, KC1 4.7, CaCl2 2.5, MgSO4 1.2, and KH2PO4 1.2. The duodenum was opened along the antimesenteric border as was the adjacent pylorus and gastric antrum. From the luminal surface, the ampulla of Vater was identified, and the SO was isolated on ice under a microscope by sharp dissection.
Preparation of SNAC SNAC was prepared at 250C by reacting equimolar (200 mM) concentrations of N-acetylcysteine (NAC) (Sigma Chemical Co., St. Louis, MO) diluted in 0.5 N HCl, with sodium nitrate (NaNO2) (Fisher Scientific, Fairhaven, NJ), diluted in deionized H20. The reaction between NaNO2 and NAC under acidic conditions is stoichiometric and essentially complete as confirmed by the method of Saville (22, (33) (34) (35) (36) . The product SNAC demonstrated a reddish hue with absorption maxima at 335 and 554 nm (22 
Ex vivo bioassay
Each isolated rabbit SO was cannulated in a retrograde fashion sequentially with a triangular stirrup and a fixed bar of a ring-type tissue mount and connected to a force-displacement transducer (Grass Instrument Co., Quincy, MA). The tissue was suspended in 10 cm3 of continuously oxygenated (95% 02, 5% C02) Krebs buffer at 37°C. After 60 min of equilibration under a load of 100 mg, the load was increased to 250 mg, and circular contractions were recorded as changes in isometric force on a polygraph (model 7E; Grass Instrument Co.). Varying concentrations of SNAC were added to the organ bath, and the effects on unstimulated SO contraction frequency and amplitude were monitored. Acetylcholine (ACH; Sigma Chemical Co.) was prepared as a 1 M stock solution in deionized H20 and stored frozen. Varying concentrations of ACH were added to organ baths, and effects on SO basal pressure were monitored. In some experiments, SO (station pull-through) (37) . The position of the catheter was stationed at a point where the middle perfusion port was in the sphincteric zone. From this position, the proximal port lay in the duodenal lumen, immediately adjacent to the papilla. The proximal port was then disconnected from the recorder, and, after a stable baseline was obtained, 10 ml 0.5 N HCl diluted 1:1,000 in normal saline was infused over 20 s as a control. Recordings were taken for 2-4 min, after which 10 cm3 10-4 M SNAC was infused over 20 s, and recordings continued for up to 10 min. The length of recording varied depending on petient cooperation and the ability to maintain the catheter fixed in position. Subjective assessments of duodenal motility were monitored on video during the procedure. In one patient in whom deep cannulation with the manometry catheter could not be obtained, duodenal motility was recorded before and after administration of 10 ml 10-4 M SNAC by advancing the perfusion catheter more distally in the duodenum and withdrawing the duodenoscope into the stomach. Patients' heart rate, blood pressure, and percent oxygen saturation were monitored noninvasively (Propaq; Protocol Systems, Inc., Beaverton, OR) throughout the procedure. Following the protocol, diagnostic ERCP was performed.
Statistics
SO contraction frequency and basal pressure before and after SNAC were compared using the paired t test. (Fig. 3) . This effect was noted within seconds and decayed over 5 min. Preincubation (2 min) with SNAC resulted in a concentration-dependent inhibition of ACH (iO-' M) induced elevations in basal pressure (Fig. 4) pressure (12.5/mmHg, P c 0.05). An apparent marked inhibition of duodenal motility was also noted on video within 30 s of SNAC infusion in all patients. In one patient whose ampulla could not be cannulated, duodenal motility was monitored manometrically after 10 cm3 sham infusion of 10-4 M SNAC. The pronounced decrease in duodenal motility after SNAC administration is shown in Fig. 6 . Heart rate, blood pressure, and percent oxygen saturation varied during the procedure in relation to the level of sedation and dosage of midazolam administered. No changes were noted after SNAC administration, no significant hemodynamic or heart rate changes were observed, and all patients tolerated the procedure well. On follow-up, no complications or unusual symptoms were reported.
Discussion
This study is the first to demonstrate the presence of nc-NOS activity in nerve fibers that course through the submucosa of The recent interest and characterization of S-nitrosothiols stems from three broad areas of research, namely the mechanism of action of the NO-generating vasodilators, (i.e., glyceryl trinitrate [TNG] , sodium nitroprusside, and isosorbide dinitrate), the identification of the endogenous vasodilator endotheliumderived relaxing factor, and the paradoxical servoregulatory and cytotoxic properties of NO. As a result of previous studies, it appears that the active metabolite of the nitrogen-containing vasodilators is NO or RS-NO and that endothelium-derived relaxing factor has similar properties (38) (39) (40) . NO, or a closely related compound, then activates guanylyl cyclase, resulting in elevation of cellular cyclic GMP, an inhibitor of smooth muscle contraction (41) (42) (43) . At the same time, NO and related donors may exhibit considerable toxicity, particularly in settings of oxidant stress and in acidic environments as found in the gut (44, 45) . In this context it has been suggested that the reaction of NOx with tissue sulfhydryl groups may serve to limit formation of mutagenic nitrosamines as well as potential deleterious reaction of NO with reactive oxygen intermediates (19, 44) . Indeed, S-nitrosothiols have been identified in human airways in vivo in states predisposing to O2-dependent toxicity (44, 45 ) , and a much earlier literature strongly suggests that they form in the GI tract (26, 45) .
Of interest, sodium nitroprusside has been used in animal studies to obliterate SO motility, although its mechanism of action has not been addressed (46). In humans, systemically administered TNG has been demonstrated to lower SO basal pressure and contraction amplitude measured manometrically in patients undergoing ERCP, and gallstones have been removed from an intact papilla after TNG-induced "chemical sphincterotomy" (47) (48) (49) . In these studies, TNG did not affect SO contraction frequency, and effects on duodenal motility were not evaluated. Moreover, the therapeutic value of TNG may be compromised by systemic hypotension. In our study, we saw a significant inhibition in both SO basal pressure (22, 23) . It is more likely that metabolism of RS-NO involves transfer of the NO moiety (as NO ') to thiol functionalities on the cell surface (23, 53, 54) . This reaction would be critically influenced by endogenous redox conditions and pH in the proximity of the mucosa (55) , potentially contributing to the observed patient variability. Further experiments aimed at elucidating these mechanisms are ongoing.
When administered intravenously to rabbits, SNAC results in a profound decrease in systemic blood pressure within seconds; this hypotensive effect lasts several minutes (51) . In superfusion studies using isolated GI and non-GI muscle, the duration of action of S-nitrosothiols is on the order of minutes (3, 25) . In our animal studies, the inhibitory effects of SNAC were present at 1 h, and over 90% of the initial concentration of SNAC, as measured by the method of Saville, remained nonmetabolized in the bath (data not shown). SO motility returned within minutes of washing the tissue with fresh Krebs buffer, suggesting that the rate-limiting step in our model is delivery of NO (or a related redox form) to the smooth muscle cells. In human studies, manometric data were obtained only up to 10 min, as recordings beyond this time point were technically limited, and, thus, data on duration of action were not obtained. 
